Genetic Testing

Genetic Testing

Global Genetic Testing Market to Reach US$26.4 Billion by 2030

The global market for Genetic Testing estimated at US$13.7 Billion in the year 2023, is expected to reach US$26.4 Billion by 2030, growing at a CAGR of 9.8% over the analysis period 2023-2030. Prenatal & Newborn Genetic Testing, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$8.9 Billion by the end of the analysis period. Growth in the Diagnostic Genetic Testing segment is estimated at 9.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$5.5 Billion While China is Forecast to Grow at 11.9% CAGR

The Genetic Testing market in the U.S. is estimated at US$5.5 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.0 Billion by the year 2030 trailing a CAGR of 11.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.1% and 9.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.5% CAGR.

Global Genetic Testing Market - Key Trends & Drivers Summarized

What Is Genetic Testing and How Does It Impact Healthcare?
Genetic testing involves analyzing DNA sequences to identify changes in genes, chromosomes, or proteins that could indicate the presence of or risk for developing genetic disorders. This type of testing has revolutionized the medical field by enabling early diagnosis and personalized treatment plans for a wide array of diseases, including cancers, cardiovascular diseases, and rare genetic disorders. By identifying specific genetic mutations, healthcare providers can tailor treatments to individual patients, enhancing treatment efficacy and potentially reducing side effects. Genetic testing also plays a pivotal role in prenatal screening, carrier screening, and in predicting an individual’s risk of developing certain diseases.

What Technological Advancements Are Shaping Genetic Testing?
The field of genetic testing has been profoundly impacted by advancements in genomic technologies, particularly next-generation sequencing (NGS) and CRISPR. NGS allows for the rapid sequencing of entire genomes at a fraction of the cost and time previously required. This technology has not only expanded the accessibility of genetic testing but also improved the accuracy and reliability of the results. Meanwhile, CRISPR technology, known for its gene-editing capabilities, is being explored for its potential to correct genetic defects before they can lead to disease. Additionally, improvements in bioinformatics and the integration of artificial intelligence have enhanced the ability to analyze and interpret large sets of genetic data, providing more detailed and actionable insights.

How Are Regulatory and Ethical Considerations Influencing the Genetic Testing Market?
The genetic testing market is heavily influenced by regulatory and ethical considerations. As genetic testing becomes more commonplace, issues such as privacy, consent, and access to genetic information have prompted governments worldwide to establish strict guidelines and regulations. These regulations aim to protect individuals from genetic discrimination and ensure that genetic data is handled with confidentiality and integrity. Furthermore, ethical concerns regarding how genetic testing is used—for example, in prenatal screening or for determining the likelihood of developing late-onset diseases—continue to shape public policy and influence consumer acceptance and trust in genetic testing services.

What Drives the Growth in the Genetic Testing Market?
The growth in the genetic testing market is driven by several factors, including the increasing prevalence of genetic disorders, technological advancements in genetics, and a growing awareness of the benefits of early disease detection and prevention. The expansion of direct-to-consumer genetic testing kits has also significantly contributed to market growth, as more individuals take proactive steps towards understanding their genetic health. Additionally, healthcare systems are increasingly adopting personalized medicine practices, which rely heavily on genetic insights to craft individualized treatment plans. Moreover, ongoing research and development activities, supported by funding from governments and private entities, are continually uncovering new applications for genetic testing, further broadening the market`s scope.

Select Competitors (Total 249 Featured) -

• Agilent Technologies, Inc.
• Asuragen, Inc.
• Biocartis NV
• Agena Bioscience, Inc.
• ARUP Laboratories
• Bioiberica SAU
• AutoGenomics, Inc.
• Biodesix, Inc.
• Admera Health
• Annoroad Gene Technology
• Berry Genomics Co., Ltd.
• Ariel Precision Medicine, Inc.
• AlphaBiolabs Ltd.
• AnchorDx
• Alexian Brothers of America, Inc.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.